• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Ed Haislmaier: Impact of Business Coalitions on Healthcare Costs

Video

Ed F. Haislmaier, the Preston A. Wells Jr senior research fellow at the Institute for Family Community, and Opportunity at The Heritage Foundation, talks about the impact of new business partnerships on healthcare costs.

Ed F. Haislmaier, the Preston A. Wells Jr senior research fellow at the Institute for Family Community, and Opportunity at The Heritage Foundation, talks about the impact of new business partnerships on healthcare costs.

Transcript

What impact do you see of recent nontraditional mergers and partnerships — CVS-Aetna and Amazon-JP Morgan-Berkshire Hathaway – having on healthcare costs?

I’m keeping an open but skeptical mind about both of those partnerships. I’m not sure about the CVS-Aetna partnership as really creating that much synergy. I’m willing to be persuaded but it just doesn’t seem to be a synergistic approach. The question about Amazon and Berkshire and JP Morgan Chase—that is even less clear. It does seem to have the feel of large employers getting together to finally figure out how to buy smarter, which is something we’ve seen happen before with mixed results.

We’ve had business coalitions on healthcare and things like that. Both of those are very early stages and I’m willing to say that something might happen, but I’m skeptical on both.

The Center for American Progress recently released a framework called Medicare Extra for All, similar to Senator Bernie Sanders’ own proposal — what is your take on these types of proposals?

The basic problem that they’re trying to address is the so-called uninsurance. I’m not sure how many uninsured people we actually have left because functionally most of the people, if people are technically insured, a lot of them are functionally insured. In other words, they have access to care, they’re just not in an insurance program.

This is kind of interesting because we’ve seen this with the Affordable Care Act is we’ve seen people get the Affordable Care Act insurance when they need medical care and then drop it. So, do you count those people as insured or uninsured? Because once they’ve been treated, they drop the insurance.

I think the goal of insurance for everybody, while it sounds nice, is really a secondary. The primary goal I think we need to focus on are people getting access to the medical care that they need. How we do that, how we pay for it, becomes a secondary issue.

Related Videos
Kimberly Westrich, MA, chief strategy officer at the National Pharmaceutical Council
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Jawad Haider Butt, MD, PhD
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Barry Byrne, MD, PhD, Powell Gene Therapy Center at the University of Florida
JC Scott, CEO and president, PCMA
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Adam Colburn, JD, vice president for congressional affairs, AMCP
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.